NFKB1 and cancer: Furthermore, metformin modulates expression of macrophage-related cytokines, thereby suppressing the ability of cancer cells to promote the protective macrophage 2 phenotype and promoting the anti-cancer macrophage 1 phenotype in an AMPK/NF-κB-dependent manner [151,152].